Perrigo Company

Perrigo Company is an Irish–registered manufacturer of private label over-the-counter pharmaceuticals. Perrigo engages in the acquisition (for repricing), manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States. The company was founded in 1887 in Allegan, Michigan, by Luther and Charles Perrigo.
Perrigo Company stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Perrigo Company balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Perrigo Company cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Perrigo Company multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Perrigo Company profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Perrigo Company assets
Perrigo Company cash flows
Perrigo Company dividends
3.51%

Perrigo Company dividend policy

The company pays dividends quarterly

Perrigo Company shares

TickerNameTypeNominal valueISINPrice
PRGO:USPerrigo Company plcCommon share-IE00BGH1M568$27.51
Perrigo Company news
11.05.2022
Perrigo Company's GAAP loss for 3 months of 2022 was $2.4 million, compared to a loss of $38.1 million in the previous year. Revenue increased 6.4% to $1.075 billion from $1.01 billion a year earlier.
Source: {source} pictogram investor.perrigo.com
Pictogram next
05.05.2022
The Perrigo Company Board of Directors announced a quarterly dividend of $0.26 per share. The last day to buy securities to receive the dividend is June 1, 2022. The annual dividend yield may reach 2.65%.
Source: {source} pictogram investor.perrigo.com
Pictogram next
02.05.2022
Perrigo Company completed its €1.8 billion acquisition of HRA Pharma, a health care products company. The deal will allow Perrigo to increase revenues and EPS for fiscal year 2023 by €400 million and $1, respectively.
Source: {source} pictogram investor.perrigo.com
Pictogram next
01.03.2022
Perrigo Company's GAAP loss for 2021 was $68.9 million, down 2.4 times from $162.6 million in the previous year. Revenue increased 1.2% to $4.139 billion from $4.088 billion a year earlier.
Source: {source} pictogram investor.perrigo.com
Pictogram next
All Perrigo Company news
General information
Company namePerrigo Company
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business addressTREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 L2 2 269-673-8451
Mailing address515 EASTERN AVENUE ALLEGAN MI 49010
Websitewww.perrigo.com
Information disclosurewww.sec.gov